数据链接：
官方服务：
资源简介：
HIV pre-treatment drug resistance in Nicaragua.
应用场景：
创建时间：
2016-10-14
相关数据集
Frequency of occurrence of mutations and/or polymorphisms in protease by HIV subtypes.
Frequency of occurrence of mutations and/or polymorphisms in protease by HIV subtypes.
NIAID Data Ecosystem50
ATN 082 Study Drug Adherence Primary Dataset in Acceptability and Feasibility of a Pre-Exposure Prophylaxis Trial With Young Men Who Have Sex With Men
Data from Study Drug Adherence Form [CRF 74; Header information and Questions 2-4] Study Description An exploratory mixed-methods study comparing a behavioral HIV-prevention intervention (Many Men, M
NIAID Data Ecosystem40
Ready to Rerandomize CRF in Technology-Based Stepped Care to Stem Transgender Adolescent (TechStep) Risk Transmission
Data from the Ready to Rerandomize CRF at 3 month visit making sure ppt qualifies to be rerandomized Study Description TechStep was a three-arm, technology-based randomized controlled trial (RCT), wit
NIAID Data Ecosystem20
Understanding willingness to use oral pre-exposure prophylaxis for HIV prevention among men who have sex with men in China
Background: Oral pre-exposure prophylaxis (PrEP) is recommended as an additional prevention choice for men who have sex with men (MSM) at substantial risk of HIV. The aim of this study was to evaluate
DataONE2020-06-24 更新50
Computational study of protein specificity: The molecular basis of HIV-1 protease drug resistance
Drug resistance has sharply limited the effectiveness of HIV-1 protease inhibitors in AIDS therapy. It is critically important to understand the basis of this resistance for designing new drugs. We ha
PubMed Central2001-12-18 更新30
